We are the only consultancy company with focus on extracellular vesicles and exosomes. At Exosome Consulting we specialize in helping investors and biopharma companies to identify opportunities and overcome challenges in the field of exosome-based therapies, diagnostics, and services. We are focusing on developing strategies for research and development for pharmaceutical and biotechnology companies, and providing technical due diligence for investors considering investing in companies working on extracellular vesicle-based products and technologies. Our firm conviction is that extracellular vesicles can be a long-awaited paradigm shift that will revolutionize many industries. As firm believers in exosomes, we keep our fingers on the pulse of these rapidly developing technologies and expanding marketplace. Also, we are always looking for ways to help our academic clients to bring their exosome-based discoveries to the market.
Externer Link zu Exosome Consulting
Bavaria, DE
Exosome Consulting hat dies direkt geteilt
🌟 The Japan Patent Office has issued a Notice of Allowance for our ExoPTEN patent! 🌟 This milestone expands our coverage in a crucial market, supporting our innovative therapy aimed at promoting nerve growth and regeneration after spinal cord injury. #NurExone #Biotech #ExoPTEN #RegenerativeMedicine #Patent #SpinalCordInjury #Innovation #Japan #CNSRecovery https://lnkd.in/dAfpxeXZ
The FDA is currently seeking public feedback until July 30th on the draft guidance document titled "Considerations for the Use of Human and Animal-Derived Materials in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products." This guidance aims to provide recommendations for the use of materials derived from human and animal cells in the manufacturing of cell and gene therapy (CGT) products and tissue-engineered medical products (TEMPs). The document specifically addresses considerations for the inclusion of cell-derived materials, such as #extracellularvesicles, including #exosomes (called 'cell-derived particles' in the document). These components are critical in the manufacturing process as they can influence the safety and efficacy of the final therapeutic products. The guidance seeks to ensure that such materials meet regulatory standards for quality and safety, and it outlines the necessary steps for risk assessment and mitigation strategies in the use of these biological materials. #FDA #CellTherapy #Biologics #Biotechnology #RegulatoryAffairs #Biopharma #MedicalDevices #HealthcareInnovation #ClinicalTrials #PublicHealth #exosomes #extracellularvesicles #lifescience
joint March–April SOV is here… #extracellularvesicles #exosomes #biotech #pharma #therapies #drugdiscovery #lifescienceindustry #investing #biotechinnovation #investing #BiotechInnovation, #HealthcareSolutions, #StartupGrowth, #MedicalTechnology, #TherapeuticAdvances, #BiomedicalResearch, #InvestInHealth, #LifeSciencesVC, #BiotechFunding, #DisruptiveMedTech
Exosome Consulting hat dies direkt geteilt
Prof. Dr. rer. nat., Lecturer and Research Group Leader, University of Mainz
Save date for #ISEV2025 in Vienna. Looking forwad to co-chair with Eva Rohde and to work with a wonderful team to build an exciting program: Andreas Möller, 李博, Edith Buzas, Wolfgang Holnthoner, Sun Young Lee, Mario Gimona, Lucia Languino, An Hendrix, ISEV Admin. Enjoy #ISEV2024 now, and see you next year in Vienna 🎡 🎭
Just a few days left until ISEV 2024 in Melbourne (May 8-12)! If you're interested in exploring how we can help de-risk your project or investment, enhance your pipeline, or if you just want to say hello, let's meet! Please send an email to info@exosomeconsulting.com with your name, company name, and your availability between May 8 and May 12. Looking forward to connecting! #exosomes #extracellularvesicles #biotech #ISEV2024 #Melbourne
Exosome Consulting hat dies direkt geteilt
Research Director at INSERM; Brain-C Lab, Sorbonne Univ. — Cell Resilience Before Disease offers a new perspective on public health — Our goal is to restore brain resilience capabilities against degenerative diseases.
Join the Young-Network of #FSEV (YN-FSEV) on Slack, and do not miss their first webinar! YN-FSEV goes live on Slack! This platform will enable you to share your questions, thoughts and network with other early-career EV researchers: troubleshooting advice, local initiatives, you are welcome to discuss about any EV-related topics. To join YN-FSEV, you just have to fill the form (see below) and accept the charter to guarantee a safe and professional space for everyone. All you'll have to do after is click on the link you will receive on your email address. You can see this space as cocktail-chatting during a congress: be friendly, helpful, but also careful about what you will share! This platform is moderated and it is now open to postdocs, PhD students and master students. JOIN YN-FSEV: https://lnkd.in/eVgq_WyH #extracellularvesicles #science #biology #educationmatters #careerdevelopment
Have you invested in #ExtracellularVesicles, also known as #Exosomes? Are you wondering why it's taking so long to see any returns? Or perhaps you're questioning why your startup hasn't delivered on the promises made during its pitch? Join our webinar, 'Investing in Bubbles: Are Extracellular Vesicles Flops or Pops?' to discover answers to these questions and more about exosome-focused startups. Click the link below to register: https://lnkd.in/dEaKrjzj #Biotech #Investing #HealthTech #StartupInvesting #VentureCapital #InnovationInHealthcare #MedicalResearch #LifeSciences #BiotechInvesting #StartupInvesting #HealthcareInnovation #InvestmentOpportunity #Aging
ReNeuron Group Plc enters administration. The comapny anounced appointment of Cork Gully LLP as administrators. It is not known at present how much, if any, value will be returned to shareholders following the administration process. #extracellularvesicles #BiotechInvestments #venturecapital #healthcareinnovation #biotechnology #medicalscience #investmentopportunities #healthcarestartups #therapeutics #DiagnosticsInnovation #regenerativemedicine #investing #biopharmaceuticals #HealthcareMarketPotential #EmergingMedicalTechnologies #biologics #biologicals #startupfunding #emergingtech #ventures #returnoninvestment
Are you considering investing in the extracellular vesicle space, or perhaps you have already invested but are uncertain about the future of your investment? Exosome Consulting extends an exclusive invitation to investment professionals and venture capitalists for a premier online event, "Investing in Bubbles: Are Extracellular Vesicles Flops or Pops?" #extracellularvesicles #BiotechInvestments #venturecapital #healthcareinnovation #biotechnology #medicalscience #investmentopportunities #healthcarestartups #therapeutics #DiagnosticsInnovation #regenerativemedicine #investing #biopharmaceuticals #HealthcareMarketPotential #EmergingMedicalTechnologies #biologics #biologicals #startupfunding #emergingtech #ventures #returnoninvestment
Exosome Consulting hat dies direkt geteilt
Colleagues and connections, I will be in Cambridge, MA and NYC this week attending Funding Biopharma Innovation held by FT Live at The Charles Hotel on Tuesday, March 12th followed by MassBio's St. Patrick's Day Mixer on Thursday, March 14th. If you are in the Boston or NYC area and interested in learning more about our small Extracellular Vesicle Therapeutic pipeline and Series A opportunity, do not hesitate to reach out directly and schedule a meeting with me and frederick naftolin, Chair of our Medical & Scientific Advisory Board. We expect to meet with the FDA in the Summer of 2024 and look forward to reviewing our lead program progress and traction. #exosomes #extracellularvesicles #nanoparticles #drugdelivery #neurology #nervepain #chronicpain #chronicpainrelief #innovation Portal Innovations, LLC frederick naftolin Matthew Peterson Alacrita Consulting